With the premise of better structural design, easy rotatability and less valve-related complications CarboMedics cardiac prosthesis (CarboMedics, Inc., Austin, Texas) was launched in 1986. We reviewed our experience with 165 implants in a group of mostly rheumatic heart disease patients with a follow-up period of at least seven years and a maximum of ten years. There was no hospital mortality, significant morbidity or thromboembolism and no patient to date has experienced any valve-related event. We conclude that the clinical performance is quite satisfactory and it improves the quality of life in patients with cardiac valve prostheses. We find the rotatability feature is particularly useful especially in situations where the entire mitral apparatus is preserved during mitral valve replacement.
CopelandJ. G.III, An international experience with the CarboMedics prosthetic heart valve. J. Heart Valve Dis, 1995, 4, 56–62.
2.
CopelandJ. G.III, and SethiG. K.North American team of clinical investigators for the CarboMedics prosthetic heart valve Four-year experience with the CarboMedics valve: the North American experience. Ann. Thorac. Surg, 1994, 58, 630–638.
3.
BernalJ. M., RabasaJ. M., Gutierrtv.-GarciaF.The CarboMedics Valve: Experience with 1049 implants, Ann. Thorac. Surg., 1998, 65, 137–143.
4.
EdmundsL. H.Jr., ClarkR. E., CohnL. H., GrunckmeierG. L., MillerD. C. and WeiselR. D.Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann. Thorac. Surg, 1996, 62, 932–935.
5.
DuranC.M.G., GometzaB. and DeVolB., Valve repair in rheumatic mitral disease, Circulation, 1991, 84 (Suppl. 3), 125–132.
6.
FerrazziP., McGriffenD. C., KirklinJ. W., BlackstoneE. H. and BourgeR. C.Have the results of mitral valve replacement improved?J. Thorac. Cardiovasc. Surg, 1986, 92, 186–197.
7.
ChristakisG. T., WeiselR. D., FremesS. E.Can the results of contemporary aortic valve replacement be improved ?J. Thorac. Cardiovasc. Surg, 1986, 92, 37–46.
8.
AromK. V., NicolofD. M., KerstenT. E.Ten-year follow up study of patients who had double valve replacement with the St. Jude medical prosthesis. J. Thorac. Cardiovasc. Surg, 1989, 98, 1008–1016.
9.
LindblomD., LindblomU. and AbergB.Long-term clinical results after combined aortic and mitral valve replacement. Eur. J. Cardiothorac. Surg, 1988, 2, 347–354.
EdmundsL. H.Thrombotic and bleeding complications of prosthetic heart valves (Collective Review). Ann. Thorac. Surg, 1987, 44, 430–445.
12.
AromK. V., NicoloffD. M., KerstenT. E., LindsayW. G. and NorthupW. F.St Jude medical prosthesis: Valve-related deaths and complications. Ann. Thorac. Surg., 1987, 43, 591–598.
13.
ShoevaerdtsJ. C., BucheM., GarianiA.Twenty years' experience with the Model 6120 Starr-Edwards valve in the mitral position. J. Thorac. Cardiovasc. Surg., 1987, 94, 375–382.
14.
CortinaJ. M., MartinelliJ., ArtizV., FraileJ. and RabagoG.Comparative clinical results with Omniscience (STMI), Medtronic—Hall and Bjork—Shiley convexo-concave (70 degrees) prosthesis in mitral valve replacement. J. Thorac. Cardiovasc. Surg, 1986, 91, 174–183.
15.
HorstkotteD., HaertenK., HerzerJ. A., LoogenF., ScheiblingR. and SchulteH. D.Five-year results after randomized mitral valve replacement with Bjork—Shiley, Lillehei—Kaster and Starr—Edwards prostheses. Thorac. Cardiovasc. Surg, 1983, 31, 206–214.
16.
MillerD. C., OyerP. E., StinsonE. B., ReitzB. A., JamiesonS. W., BaumgartnerW. A., MitchellR. S. and ShumwayN. E.Ten-to-fifteen-year reassessment of the performance characteristics of the Starr—Edwards Model 6120 mitral valve prosthesis. J. Thorac. Cardiovasc. Surg., 1983, 85, 1–20.
17.
TeplyJ. F., GrunkmeierG. L., SutherlandH. D., LambertL. E., JohnsonV. A. and StarrA.The ultimate prognosis after valve replacement: an assessment at twenty years. Ann. Thorac. Surg, 1981, 32, 111–119.
18.
KarpR. B., CyrusR. J., BlackstoneE. H., KirklinJ. W., KouchoukosN. T. and PacificoA. D.The Bjork—Shiley valve: Intermediate-term follow-up. J. Thorac. Cardiovasc. Surg, 1981, 81, 602–614.
19.
WilliamsJ. B., KarpR. B., KirklinJ. W., KouchoukosN. T., PacificoA. D., ZornG. L.Jr.Consideration in selection and management of patients undergoing valve replacement with glutaraldehyde-fixed porcine bioprostheses. Ann. Thorac. Surg, 1980, 30, 247–258.
20.
ArmentiF., StephensinL. W. and EdmundsL. H.Jr.Simultaneous implantation of St. Jude Medical aortic and mitral prosthesis. J. Thorac. Cardiovasc. Surg, 1987, 94, 733–739.
21.
NygaardH., PaulsenP. K., HasenkarnJ. M., PedersenE. M. and RovsingP. E.Turbulent stress down stream of the of three mechanical aortic valve prostheses in human beings. J. Thorac. Cardiovasc. Surg, 1994, 107, 438–446.
22.
ButterfieldM., FisherJ., DaviesG. A. and SpytT. J.Comparative study of the hydrodynamic function of the CarboMedics valve. Ann. Thorac. Surg, 1991, 52, 815820.
23.
OrsinelliD. A., BeckerR. C., CuenoudH. F. and MoranJ. M.Mechanical failure of a St. Jude Medical prosthesis. Am. J. Cardiol, 1991, 67, 906–908.
24.
BurckhardtD., StriebelD., VogtS.Heart valve replacement with the St. Jude medical prosthesis: long-term experience in 743 patients in Switzerland. Circulation, 1988, 78(Suppl. 1), 18–24.
25.
KiyoharuN., KoyanagiH., HashimotoA.Twelve years' experience with the St. Jude Medical valve prosthesis. Ann. Thorac. Surg, 1994, 57, 697–703.
